AGIOS PHARMACEUTICALS INC Business Finance Contracts & Agreements
21 Contracts & Agreements
- Exchange Agreements (5 contracts)
- Investor Rights Agreements (1)
- Purchase Agreements (3)
- Repurchase Agreements (1)
- Stock Agreements (4)
- Underwriting Agreements (7)
- Purchase and Sale Agreement, dated October 27, 2022, by and among the Registrant (Filed With SEC on February 23, 2023)
- Form of Inducement Restricted Stock Unit Agreement (Filed With SEC on August 4, 2022)
- Form of Inducement Stock Option Agreement (Filed With SEC on August 4, 2022)
- Share Repurchase Agreement, dated as of March 31, 2021, by and between Agios Pharmaceuticals, Inc. and Bristol-Myers Squibb Company (Filed With SEC on April 2, 2021)
- Purchase and Sale Agreement, dated as of December 20, 2020, by and among Agios Pharmaceuticals, Inc., Servier Pharmaceuticals, LLC, and, solely for purposes of guaranteeing... (Filed With SEC on December 22, 2020)
- Royalty Purchase Agreement, dated as of June 11, 2020, by and between the Registrant and RPI 2019 Intermediate Finance Trust (Filed With SEC on July 30, 2020)
- Underwriting Agreement, dated November 7, 2019, by and among Agios Pharmaceuticals, Inc., J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Cowen and Company, LLC (Filed With SEC on November 8, 2019)
- Underwriting Agreement, dated January 18, 2018, by and among Agios Pharmaceuticals, Inc., J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Cowen and Company, LLC (Filed With SEC on January 19, 2018)
- AGIOS PHARMACEUTICALS, INC. 5,050,505 Shares of Common Stock Underwriting Agreement (Filed With SEC on April 19, 2017)
- AGIOS PHARMACEUTICALS, INC. 3,370,786 Shares of Common Stock Underwriting Agreement (Filed With SEC on September 15, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisk denote omissions. COLLABORATION AND LICENSEAGREEMENT by and... (Filed With SEC on August 7, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. COLLABORATION AND LICENSEAGREEMENT by and... (Filed With SEC on August 7, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. [****] denotes omissions. THIRD AMENDMENT TO DISCOVERY AND DEVELOPMENT... (Filed With SEC on February 24, 2015)
- AGIOS PHARMACEUTICALS, INC. 1,986,455 Shares of Common Stock Underwriting Agreement (Filed With SEC on December 11, 2014)
- AGIOS PHARMACEUTICALS, INC. [] Shares of Common Stock Underwriting Agreement (Filed With SEC on April 21, 2014)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on July 16, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. DISCOVERY AND DEVELOPMENT COLLABORATION AND... (Filed With SEC on July 16, 2013)
- AGIOS PHARMACEUTICALS, INC. [ ] Shares of Common Stock Underwriting Agreement (Filed With SEC on July 16, 2013)
- AGIOS PHARMACEUTICALS, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN June 15, 2013 (Filed With SEC on June 24, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. DISCOVERY AND DEVELOPMENT COLLABORATION AND... (Filed With SEC on June 10, 2013)
- AGIOS PHARMACEUTICALS, INC. SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT November 16, 2011 TABLE OF CONTENTS (Filed With SEC on June 10, 2013)
